Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea flag South Korea · Delayed Price · Currency is KRW
279,500
-2,000 (-0.71%)
At close: Aug 14, 2025, 3:30 PM KST

Hanmi Pharm. Revenue

Hanmi Pharm. had revenue of 390.95B KRW in the quarter ending March 31, 2025, a decrease of -3.16%. This brings the company's revenue in the last twelve months to 1.48T, down -3.30% year-over-year. In the year 2024, Hanmi Pharm. had annual revenue of 1.50T with 0.31% growth.

Revenue (ttm)
1,482.77B
Revenue Growth
-3.30%
P/S Ratio
2.39
Revenue / Employee
636.38M
Employees
2,330
Market Cap
3,544.12B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241,495.50B4.61B0.31%
Dec 31, 20231,490.89B159.34B11.97%
Dec 31, 20221,331.55B128.36B10.67%
Dec 31, 20211,203.19B127.33B11.84%
Dec 31, 20201,075.85B-37.80B-3.39%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics4,898.69B
Celltrion3,662.23B
ALTEOGEN151.65B
Yuhan2,114.76B
Peptron4.30B
SK Biopharmaceuticals578.00B
PharmaResearch392.31B
LigaChem Biosciences146.42B
Revenue Rankings